ATE357452T1 - Sialyl-lewisa und sialyl lewisx epitop-analoge - Google Patents
Sialyl-lewisa und sialyl lewisx epitop-analogeInfo
- Publication number
- ATE357452T1 ATE357452T1 AT97901546T AT97901546T ATE357452T1 AT E357452 T1 ATE357452 T1 AT E357452T1 AT 97901546 T AT97901546 T AT 97901546T AT 97901546 T AT97901546 T AT 97901546T AT E357452 T1 ATE357452 T1 AT E357452T1
- Authority
- AT
- Austria
- Prior art keywords
- sialyl
- lewisa
- lewisx
- epitop
- analogue
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH23096 | 1996-01-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE357452T1 true ATE357452T1 (de) | 2007-04-15 |
Family
ID=4182259
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97901546T ATE357452T1 (de) | 1996-01-30 | 1997-01-17 | Sialyl-lewisa und sialyl lewisx epitop-analoge |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6169077B1 (de) |
| EP (1) | EP0886640B1 (de) |
| AT (1) | ATE357452T1 (de) |
| AU (1) | AU1542397A (de) |
| DE (1) | DE69737496D1 (de) |
| WO (1) | WO1997028173A1 (de) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2235362T3 (es) * | 1997-08-08 | 2005-07-01 | Aventis Pharma Deutschland Gmbh | Derivados de tetrahidropirano sustituidos, asi como procedimientos para su preparacion. |
| SE9904581D0 (sv) * | 1999-12-15 | 1999-12-15 | A & Science Invest Ab | A novel helicobacter pylori-binding substance and use thereof |
| US7481790B2 (en) * | 2000-12-27 | 2009-01-27 | Advanced Cardiovascular Systems, Inc. | Vessel enlargement by arteriogenic factor delivery |
| EP1534725A2 (de) * | 2002-05-16 | 2005-06-01 | Glycomimetics, Inc. | Verbindungen und verfahren zur inhibierung von selectinvermittelten funktion |
| CA2490703A1 (en) * | 2002-07-03 | 2004-01-15 | Glycomimetics, Inc. | Compositions and methods for diagnosis and therapy of medical conditions involving angiogenesis |
| JP2006515306A (ja) * | 2002-12-20 | 2006-05-25 | グリコミメティクス， インコーポレイテッド | Ｐｓｅｕｄｏｍｏｎａｓ細菌感染の処置のためのオリゴ糖およびその結合体 |
| US20040219158A1 (en) * | 2003-05-02 | 2004-11-04 | Glycomimetics, Inc. | Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria |
| EP1763533B1 (de) * | 2003-11-19 | 2008-01-09 | GlycoMimetics, Inc. | Spezifischer antagonist sowohl für e- als auch p-selektine |
| CA2546784A1 (en) * | 2003-11-19 | 2005-06-16 | Glycomimetics, Inc. | Glycomimetic antagonists for both e- and p-selectins |
| US8201377B2 (en) * | 2004-11-05 | 2012-06-19 | Faus Group, Inc. | Flooring system having multiple alignment points |
| WO2006127906A1 (en) * | 2005-05-25 | 2006-11-30 | Glycomimetics, Inc. | Heterobifunctional compounds for selectin inhibition |
| ES2375979T3 (es) * | 2005-08-09 | 2012-03-07 | Glycomimetics, Inc. | Inhibidores glicomiméticos de la lectina pa-il, lectina pa-iil o ambas lectinas de pseudomonas. |
| EP2264043B1 (de) | 2005-09-02 | 2017-11-08 | GlycoMimetics, Inc. | Heterobifunktionelle Pan-Selektin-Inhibitoren |
| WO2007143052A1 (en) * | 2006-06-01 | 2007-12-13 | Glycomimetics, Inc. | Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas |
| EP2074132B1 (de) | 2006-10-12 | 2013-05-15 | GlycoMimetics, Inc. | Glycomimetischer ersatz für hexosen und n-acetyl-hexosamine |
| EP2117561A1 (de) * | 2007-02-09 | 2009-11-18 | GlycoMimetics, Inc. | Verfahren zur verwendung von glykomimetika mit substituten für hexosen und n-acetyl-hexosaminen |
| US8039442B2 (en) | 2007-07-18 | 2011-10-18 | Glycomimetics, Inc. | Compounds and methods for treatment of sickle cell disease or complications associated therewith |
| WO2009126556A1 (en) | 2008-04-08 | 2009-10-15 | Glycomimetics, Inc. | Pan-selectin inhibitor with enhanced pharmacokinetic activity |
| AU2009257536B2 (en) * | 2008-06-13 | 2015-07-02 | Glycomimetics, Inc. | Treatment of cancers of the blood using selected glycomimetic compounds |
| JP5726171B2 (ja) * | 2009-05-01 | 2015-05-27 | グリコミメティックス インコーポレイテッド | Ｅ−セレクチンおよびｃｘｃｒ４ケモカイン受容体のヘテロ二官能性阻害剤 |
| WO2012037034A1 (en) | 2010-09-14 | 2012-03-22 | Glycomimetics, Inc. | E-selectin antagonists |
| ES2655443T7 (es) | 2011-12-22 | 2021-03-22 | Glycomimetics Inc | Compuestos antagonistas de E-selectina |
| GB201214736D0 (en) * | 2012-08-17 | 2012-10-03 | Isis Innovation | Inflammation imaging and therapy |
| SI2928476T1 (en) | 2012-12-07 | 2018-06-29 | Glycomimetics, Inc. | COMPONENTS, INSTALLATIONS AND PROCEDURES OF THE APPLICATION OF E-SELECTINE OF ANTAGONISTS FOR THE MOBILIZATION OF HEMATOPOETIC CELLS |
| CN107108679B (zh) | 2014-12-03 | 2020-10-23 | 糖模拟物有限公司 | E-选择蛋白和cxcr4趋化因子受体的异双官能抑制剂 |
| CA3009836A1 (en) | 2016-01-22 | 2017-07-27 | Glycomimetics, Inc. | Glycomimetic inhibitors of pa-il and pa-iil lectins |
| US11291678B2 (en) | 2016-03-02 | 2022-04-05 | Glycomimetics, Inc | Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin |
| JP2019524791A (ja) | 2016-08-08 | 2019-09-05 | グリコミメティクス， インコーポレイテッド | Ｅ−セレクチンの阻害剤もしくはｃｘｃｒ４の阻害剤との、またはｅ−セレクチンおよびｃｘｃｒ４両方のヘテロ二機能性阻害剤とのｔ細胞チェックポイント阻害剤の組み合わせ |
| US11072625B2 (en) | 2016-10-07 | 2021-07-27 | Glycomimetics, Inc. | Highly potent multimeric e-selectin antagonists |
| JP7272956B2 (ja) | 2017-03-15 | 2023-05-12 | グリコミメティクス， インコーポレイテッド | Ｅ－セレクチンアンタゴニストとしてのガラクトピラノシル－シクロヘキシル誘導体 |
| WO2019108750A1 (en) | 2017-11-30 | 2019-06-06 | Glycomimetics, Inc. | Methods of mobilizing marrow infiltrating lymphocytes and uses thereof |
| CN111566117A (zh) | 2017-12-29 | 2020-08-21 | 糖模拟物有限公司 | E-选择蛋白和半乳凝素-3的异双功能抑制剂 |
| CN111867601A (zh) | 2018-03-05 | 2020-10-30 | 糖模拟物有限公司 | 用于治疗急性髓系白血病及相关病症的方法 |
| US11845771B2 (en) | 2018-12-27 | 2023-12-19 | Glycomimetics, Inc. | Heterobifunctional inhibitors of E-selectin and galectin-3 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4925796A (en) * | 1986-03-07 | 1990-05-15 | Massachusetts Institute Of Technology | Method for enhancing glycoprotein stability |
| PL176272B1 (pl) | 1993-05-14 | 1999-05-31 | Cytel Corp | Analogi sialilowe Le jako inhibitory adhezji komórkowej |
| SE9301677L (sv) | 1993-05-14 | 1994-11-18 | Kurt G I Nilsson | Syntesmetod |
-
1997
- 1997-01-17 WO PCT/EP1997/000222 patent/WO1997028173A1/en active IP Right Grant
- 1997-01-17 AT AT97901546T patent/ATE357452T1/de not_active IP Right Cessation
- 1997-01-17 AU AU15423/97A patent/AU1542397A/en not_active Abandoned
- 1997-01-17 EP EP97901546A patent/EP0886640B1/de not_active Expired - Lifetime
- 1997-01-17 DE DE69737496T patent/DE69737496D1/de not_active Expired - Lifetime
- 1997-01-17 US US09/117,482 patent/US6169077B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US6169077B1 (en) | 2001-01-02 |
| EP0886640A1 (de) | 1998-12-30 |
| EP0886640B1 (de) | 2007-03-21 |
| WO1997028173A1 (en) | 1997-08-07 |
| DE69737496D1 (de) | 2007-05-03 |
| AU1542397A (en) | 1997-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE357452T1 (de) | Sialyl-lewisa und sialyl lewisx epitop-analoge | |
| ATE397005T1 (de) | Sialyl-lewisa und sialyl-lewisx epitope analoge | |
| ES2101499T3 (es) | Fibras. | |
| MX9709351A (es) | Derivados de alfa-hordotionina con alto contenido de treonina. | |
| ES2128097T3 (es) | Combinaciones de herbicidas de sulfonilurea con antidotos. | |
| NO974510D0 (no) | Synergistiske blandinger av zidovudin, 1592U89 og 3TC eller FTC | |
| ES2171506T3 (es) | Mezclas de resinas de poli(ester carbonato) y de polieterimida resistentes al autoclave. | |
| BR8802492A (pt) | Composicao esterilizante e de alto grau desinfetante,inodora | |
| DE69634960D1 (de) | Stabilisatoren für lebendimpfstoffe | |
| CA2075060A1 (en) | Novel vehicle gases and their use in medical preparations | |
| NO982172L (no) | Anvendelse av epinastin for behandling av smerter | |
| MY106272A (en) | Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis, inflammation and as immunosuppressants. | |
| BR9510604A (pt) | Aperfeiçoamento do rendimento de plantas | |
| NO904676L (no) | Optisk forsterkningsenhet med lav stoey og med refleksjon av den pumpende effekt. | |
| BR9711117A (pt) | Oligossacarídios modificados. | |
| DE69023411D1 (de) | Vektorquantizierungskodierer und Dekodierer. | |
| ES2106920T3 (es) | Composicion que permite estabilizar termicamente las proteinas y producto obtenido de este modo. | |
| UY24654A1 (es) | Composición de vacuna contra la malaria | |
| EP0667790A4 (de) | Regulation der zellulären invasivität. | |
| DK0973486T3 (da) | Kosmetiske sammensætninger indeholdende en kationisk polymer med lav molekylvægt og en silicone samt deres anvendelser | |
| DE69132922D1 (de) | System zur Erzeugung von Stosswellen, welches eine Anzeige des effektiven Stosswellenbereichs erlaubt | |
| ES2172703T3 (es) | Composiciones de fluoruro de perfluoro(alcoxiciclo alcano)carbonilo, y su uso. | |
| FI895039A0 (fi) | Metoder foer behandling och foerebyggande av pneumocystis carinii-lunginflammation och andra sjukdomar samt foereningar och kompositioner, som anvaends i naemnda metoder. | |
| EP1666057A3 (de) | Ein azellulärer Impfstoff der Bordetella pertussis Antigene enthält | |
| NO984760L (no) | Anvendelse av en osmolytt ved behandling av effekter forÕrsaket av en infeksjon, en inflammasjon eller en immundysfunksjon |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |